Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Jul 7, 2017
Insider Transaction Report
Form 4
Driggs Alex
General Counsel & Corp. Sec.
Transactions
- Award
Common Stock, Class A (ESPP)
2017-06-30$8.93/sh+672$6,001→ 672 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period April 1, 2017 through June 30, 2017. This transaction is exempt under Rule 16(b)-3(c).
- [F2]In accordance with the ESPP, these shares were purchased at 85% of the June 30, 2017 closing price of the issuer's common stock.